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Abstract
The ethanol extract of heartwood from Cassia garrettiana had strong anti-HIV-1 integrase (IN) activity with an IC50
value of 3.0 µg/mL. Therefore, its fractions and compounds were investigated for their anti-HIV-1 IN effect using the multi-
plate integration assay (MIA). From bioassay-guided isolation, the ethyl acetate fraction was then separated to give five
compounds which are chrysophanol (1), piceatannol (2), aloe-emodin (3), emodin (4) and cassigarol E (5). Of the tested
samples, piceatannol (2) showed the highest activity against HIV-1 IN with an IC50 of 17.9 µM, followed by cassigarol E (5,
IC50 = 72.9 µM), respectively.  This is the first report on anti-HIV-1 IN activity of Cassia garrettiana.
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1. Introduction
Acquired immunodeficiency syndrome (AIDS) has
been rapidly spreading in many countries and is worldwide
public health problem. Three enzymes that are essential for
the  HIV-1  life  cycle  are  HIV-1  protease  (PR),  reverse
transcriptase (RT) and integrase (IN).  HIV-1 IN has become
an appealing target for AIDS treatment since there are only
two HIV-1 IN inhibitors named raltegravir and elvitegravir
that are now available in the market.  HIV-1 IN functions as
a dimer and the integration process is composed of two steps:
3 processing and 3 joining (strand transfer) which finally
integrates viral DNA into host chromosome (Katz & Skalka,
1994; Lucia, 2007). Cassia garrettiana Craib, locally known
in  Thai  as  Samae-sarn,  is  one  of  the  plants  in  the
Caesalpiniaceae  family.  In  Thai  traditional  medicine,  the
heartwood of this plant has been used as emmenagogue and
as blood tonic for women (Tewtrakul et al., 2007). Moreover,
C. garrettiana heartwood has been used to treat Herpes
zoster,  leukemia,  constipation  and  nematodes  (Boonya-
praphatsara & Chokchaicharoenporn, 1998).  C. garrettiana
has been reported to show many biological activities such as
antifungal (Inamori et al., 1984), antitumor and antimetastatic
effects (Yoshiyuki et al., 2008). Thus, searching for HIV-1 IN
inhibitors  from  natural  sources  is  becoming  an  interesting
target for AIDS treatment.
2. Materials and Methods
2.1 Plant material
Cassia garrettiana heartwoods were collected in
2010 at the Suan Ya Thai Thongnoppakhun herbal garden in
Chonburi province and were identified by a Thai traditional
doctor,  Mr. Sraupsin  Thongnoppakhun,  and  the  voucher
specimen number is SKP 072021901. The sample was kept
at  the  Herbarium  of  Department  of  Pharmacognosy  and
Pharmaceutical Botany, Faculty of Pharmaceutical Sciences,
Prince of Songkla University, Thailand.
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2.2 Isolation of compounds from Cassia garrettiana extract
The dried power of Cassia garrettiana heartwood
(2.1 kg) was extracted three times with ethanol (34 L) at room
temperature. The EtOH extract (124.4 g) was successively
partitioned to obtain hexane (8.5 g), chloroform (0.7 g), ethyl
acetate (47.2 g) and water fractions (68.0 g), respectively.
The fractions were dried under reduced pressure and then
re-dissolved in 50% DMSO for bioassay. These fractions
were prepared in the concentration of 3-100 g/mL. The ethyl
acetate fraction (10.0 g), which showed good separation on
thin layer chromatography (TLC) and exhibited marked anti-
HIV-1 IN activity (IC50 = 23.2 µg/mL), was further separated
by silica gel column chromatography using 10% CHCl3 in
methanol to afford 15 fractions (F1-F15). Fraction F2 (40.0
mg) was purified by column chromatography on Sephadex
LH-20 using 100% methanol to give chrysophanol (1) (orange
solid, 11.3 mg, 0.042% w/w). Fraction F3 (2.0 g) was purified
by column chromatography on silica gel using 10% methanol
in chloroform to give subfraction (F3/1a–F3/7a). Subfraction
F3/2a (120.0 mg) was purified by column chromatography
on  silica  gel  using  10%  methanol  in  chloroform  to  give
piceatannol (2) (white solid, 50.3 mg, 0.190% w/w). Fraction
F3/5a (600.0 mg) was purified by column chromatography on
silica gel using 20% methanol in chloroform to give cassigarol
E (5) (pale yellow solid, 207.5 mg, 0.786% w/w). Fraction
F3/7a (60.0 mg) was purified by Sephadex LH-20 using 100%
methanol  to  give  aloe-emodin  (3)  (yellow  solid,  2.0  mg,
0.007% w/w) and emodin (4) (yellow solid, 2.3 mg, 0.009%
w/w), respectively.
The  structures  of  compounds  1-5  were  elucidated
using spectroscopic techniques and compared with reported
spectral  data  (García-Sosa  et  al.,  2006;  Li  et  al.,  2005a;
Kametani et al., 2007; Yao et al., 2006; Li et al., 2005b).
2.3 Anti-HIV-1 IN assay
The inhibitory effect on HIV-1 IN activity was evalu-
ated according to a modification of the method previously
reported (Tewtrakul et al., 2001). Briefly, a mixture (45 µL),
composed of 12 µL of IN buffer [containing 150 mM 3-(N-
morpholino) propane sulfonic acid, pH 7.2 (MOPS), 75 mM
MnCl2, 5 mM dithiothritol (DTT), 25% glycerol and 500 µg/
mL bovine serum albumin], 1 µL of 5 pmol/mL digoxigenin-
labelled target DNA and 32 µL of sterilzed water, was added
into each well of a 96-well plate. Subsequently, 6 µL of sample
solution and 9 µL of 1/5 dilution of integrase enzyme was
added to each well and incubated at 37°C for 80 min. The
wells were then washed with PBS 4 times, and 100 µL of 500
mU/mL alkaline phosphatase (AP) labelled anti-digoxigenin
antibody was then added to all wells and incubated at 37°C
for  1 h.  The  plate  was  washed  again  with  washing  buffer
containing 0.05% Tween 20 in PBS 4 times and with PBS
4  times.  Then,  AP  buffer  (150  µL)  containing  100  mM
Tris-HCl (pH 9.5), 100 mM NaCl, 5 mM MgCl2 and 10 mM p-
nitrophenyl phosphate was added to each well and incubated
at 37°C for 1 h.  Finally, the plate was measured with a micro-
plate reader at a wavelength of 405 nm. A control consisted
of a reaction mixture, 50% DMSO and an integrase enzyme,
while a blank was buffer-E containing 20 mM MOPS (pH 7.2),
400 mM potassium glutamate, 1 mM ethylenediaminetetra-
acetate disodium salt (EDTA. 2Na), 0.1% Nonidet-P 40 (NP-
40), 20% glycerol, 1 mM DTT and 4 M urea without the
integrase enzyme. Suramin, a polyanionic HIV-1 IN inhibitor
was used as a positive control. The % inhibition against HIV-
1 IN was calculated as follows:
% Inhibition against HIV-1 IN =
[(OD control - OD sample)/ OD control] x 100
Where OD = absorbance detected from each well
2.4 Statistical analysis
The values are expressed as mean ± S.E.M of four
determinations.  The  IC50  values  were  calculated  using  the
Microsoft Excel programme.
3. Results and Discussion
Since  the  EtOH  extract  of  Cassia  garrettiana
possessed potent anti-HIV-1 IN effect (IC50 = 3.0 µg/mL), the
hexane,  chloroform,  ethyl  acetate  and  water  fractions  of
C. garrettiana heartwood were then tested for anti-HIV-1
IN activity.  Among  the  tested  samples,  the  water  fraction
exhibited the most potent inhibitory activity with an IC50
value of 16.9 µg/mL, followed by the ethyl acetate (IC50 =
23.2  µg/mL),  chloroform  (IC50 = 73.1 µg/mL),  and  hexane
fractions (IC50 > 100 µg/mL), respectively (Table 1). From
bioassay-guided fractionation, five compounds were isolated
from the ethyl acetate fraction of C. garrettiana and they
were each tested for anti-HIV-1 IN activity. The % inhibition
and IC50 values are shown in Table 2. The result indicated
that compound 2 (piceatannol) showed the highest activity
against HIV-1  IN  with  an  IC50  value  of  17.9  µM,  followed
by compound 5 (cassigarol E) with an IC50 value of 72.9 µM,
whereas, compounds 3, 4 and 1 were found to produce 44.8,
40.1 and 6.1 % inhibition at concentration of 100 M, respec-
tively. Piceatannol has been reported to show anti-cancer
Table 1. IC50 values of the extract and fractions of Cassia
garrettiana against HIV-1 IN activity
                    Sample IC50 (µg/mL)
EtOH extract        3.0
Hexane fraction  >100
Chloroform fraction      73.1
EtOAc fraction      23.2
Water fraction      16.9
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(Potter et al., 2002), anti-viral (Clouser et al., 2012), anti-
oxidant (Ovesná et al., 2006) and anti-inflammatory effects
(Ashikawa et al., 2002). Cassigarol E has been reported to
show anti-oxidant (Xiang et al., 2005) and anti-allergic activi-
ties (Morikawa et al., 2010). Thai medicinal plants known as
“Hua-Khao-Yen” were also reported to possess anti-HIV-1
IN activity. It was reported that the EtOH extract of Smilax
corbularia exhibited potent anti-HIV-1 IN effect with an IC50
value  of  1.9  µg/mL  (Tewtrakul  et  al.,  2006).  It  has  been
revealed that hydroxylated aromatic or catechol moiety is
crucial for the potency against HIV-1 IN (Lameira et al.,
2006). The proposed structure- activity relationships (SARs)
involved the aromatic moiety interacting with the divalent
cation in a cation  type interaction (Nicklaus et al., 1997).
There is also the possibility of a typical charge-charge inter-
action between the metal ions and ionic or partial charges of
the ligands. The catechol moiety is expected to produce IN
inhibitors by chelating a divalent metal such as Mg
2+ or Mn
2+
on the IN active site (Fan et al., 2011). Thus piceatannol (2)
and cassigarol E (5), whose structures bearing the catechol
moiety, may have a mechanism against HIV-1 IN through this
interaction. Cassigarol E (5, IC50 = 72.9 M) is a dimer of
piceatannol (2, IC50 = 17.9 M). However, it was found to
exhibit lower anti-HIV-1 IN activity than piceatannol. This
result suggests that the stearic effect of compound 5 may
interfere with the binding of this compound with the active
site of the IN enzyme.
4. Conclusions
Three anthraquinones (1, 3 and 4) and two stilbene
derivatives (2, 5) were isolated from the heartwood of Cassia
Table 2. % Inhibition
a and IC50 values of isolated compounds from ethyl acetate fraction
of C. garrettiana against HIV-1 IN activity
      % Inhibition at various concentrations (mM)
             Compound
10 30        100   IC50 (µM)
Chrysophanol   (1) - - 6.1±3.9 >100
Piceatannol       (2) 44.3±3.6 53.1±3.3 85.6±2.8 17.9
Aloe-emodin     (3) - - 44.8±0.8 >100
Emodin             (4) - - 40.1±2.7 >100
Cassigarol E     (5) 13.7±3.8 25.4±4.7 65.6±4.6 72.9
Suramin(positive control) 60.4±1.7 82.4±1.3 83.1±0.7 7.0
aEach
 value represents mean ± S.E.M. of four determinations.
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garrettiana.  It  is  concluded  that  piceatannol  (2)  and
cassigarol E (5) are responsible for anti-HIV-1 IN activity of
C. garrettiana.  Based  on  anti-HIV-1  IN  activity  of  C.
garrettiana  and  its  compounds,  it  is  suggested  that  this
plant might be useful for treatment of AIDS.
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